Nello Mainolfi - May 19, 2021 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Executive Officer, Director
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol: KYMR
Transactions as of: May 19, 2021
Transactions value $: $31,200
Form type: 4
Date filed: 5/19/2021, 05:56 PM
Previous filing: May 14, 2021
Next filing: Jun 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$31.2K	+15K	+3.78%	$2.08^*	412K	May 19, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-15K	-9.91%	$0.00	136K	May 19, 2021	Common Stock	15K	$2.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date.